Author

Armand Vincent Russo

Observed name: Armand Russo

Institutions: Yale Cancer Center, Yale University

Observed institutions: Yale Cancer Center, Yale University

OpenAlex ID: A5000231442

Bullous hemorrhagic dermatosis is an under-recognized side effect of full dose low-molecular weight heparin: a case report and review of the literature

2018 · Armand Russo, Susanna Curtis, et al. · Experimental Hematology and Oncology · 26

A rare case of visceral leishmaniasis in an immunocompetent traveler returning to the United States from Europe

2018 · Lamia Haque, Merceditas Villanueva, et al. · PLoS neglected tropical diseases · 16

Defining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency

2022 · Junghee Jenny Shin, Jennefer Par-Young, et al. · Journal of Clinical Immunology · 14

Molecular predictors and immunomodulatory role of dual checkpoint inhibitor blockade using ipilimumab/nivolumab in patients with extensive stage small cell lung cancer.

2023 · Anne C. Chiang, Hossein Asghari, et al. · Journal of Clinical Oncology · 1

A pilot study of ipilimumab and nivolumab in recurrent extensive-stage small cell lung cancer after platinum-based chemotherapy.

2022 · Anne C. Chiang, Matthew Austin, et al. · Journal of Clinical Oncology · 1

Burden and survival outcome of secondary malignancies in Waldenström macroglobulinemia (WM)/lymphoplasmacytic lymphoma (LPL): A population-based analysis using Surveillance, Epidemiology, and End Results (SEER 2000-2022).

2026 · Saurav Das, Harshit Arora, et al. · Journal of Clinical Oncology

Comparative survival disparities and outcome in primary vs secondary central nervous system lymphoma (CNSL): A population-based analysis using Surveillance, Epidemiology, and End Results (SEER) program (2000-2022).

2026 · Harshit Arora, Saurav Das, et al. · Journal of Clinical Oncology

CRE26-064: Evolving Clonal Landscape of VEXAS Syndrome Associated With Myelodysplastic Syndrome: Single Centered, 2 Years Longitudinal Study

2026 · Saurav Das, Armand Russo · Journal of the National Comprehensive Cancer Network

Real world treatment outcome with azacytidine (AZA)-tocilizumab (TCZ) for reducing steroid dependence in vexas syndrome with myelodysplastic syndrome (MDS): A single-center, 1.5-year longitudinal observational study

2025 · Saurav Das, Armand Russo · Blood

Clinical features associated with an exceptional response to immunotherapy in patients with metastatic non-small cell lung cancer (NSCLC).

2025 · Yunan Nie, Anna Wurtz, et al. · Journal of Clinical Oncology

Spectrum and Management of Immune Related Adverse Events Due to Immune Checkpoint Inhibitors

2021 · Marianne Davies, Armand Russo · Current cancer research

Works count: 11

Citation count: 58

H-index: 3

I10-index: 3